Treatment-induced diabetic neuropathy: a reversible painful autonomic neuropathy.
Treatment-induced diabetic neuropathy: a reversible painful autonomic neuropathy.
复制标题
DOI:
10.1002/ana.21952
复制
发表时间:
2010-04
影响因子:
11.2
通讯作者:
Freeman, Roy
中科院分区:
文献类型:
--
作者:
Gibbons, Christopher H.;Freeman, Roy
To describe the natural history, clinical, neurophysiological and histological features and outcomes of diabetic patients presenting with acute painful neuropathy associated with glycemic control, also referred to as ‘insulin neuritis’. Sixteen subjects, presenting with acute painful neuropathy had neurological and retinal examinations, laboratory studies, autonomic testing and pain assessments over 18 months. Eight subjects had skin biopsies for evaluation of intra-epidermal nerve fiber density. All subjects developed severe pain within 8 weeks of intensive glucose control. There was a high prevalence of autonomic cardiovascular, gastrointestinal, genitourinary, and sudomotor symptoms in all subjects. Orthostatic hypotension and parasympathetic dysfunction were seen in 69% of subjects. Retinopathy worsened in all subjects. Reduced intra-epidermal nerve fiber density (IENFD) was seen in all tested subjects. After 18 months of glycemic control, there were substantial improvements in pain, autonomic symptoms, autonomic test results and IENFD. Greater improvements were seen after 18 months in type 1 vs. type 2 diabetic subjects in autonomic symptoms (cardiovascular p<0.01; gastrointestinal p<0.01; genitourinary p<0.01) and autonomic function tests (p<0.01, sympathetic and parasympathetic function tests). Treatment induced neuropathy is characterized by acute, severe pain, peripheral nerve degeneration and autonomic dysfunction after intensive glycemic control. The neuropathy occurred in parallel with worsening diabetic retinopathy suggesting a common underlying pathophysiological mechanism. Clinical features and objective measures of small myelinated and unmyelinated nerve fibers can improve in these diabetic patients despite a prolonged history of poor glucose control, with greater improvement seen in patients with type 1 diabetes.
登录
查看更多内容
影响因子:
8.2
作者:
ARCHER, AG;ROBERTS, VC;WATKINS, PJ
通讯作者:
WATKINS, PJ
影响因子:
9.9
作者:
Lauria, G;Morbin, M;Pareyson, D
通讯作者:
Pareyson, D
影响因子:
8.2
作者:
Malik, RA;Tesfaye, S;Ward, JD
通讯作者:
Ward, JD
影响因子:
16.2
作者:
Dotson, Sarah;Freeman, Roy;Adler, Gail K.
通讯作者:
Adler, Gail K.
影响因子:
4.1
作者:
Chantelau, E
通讯作者:
Chantelau, E